Track topics on Twitter Track topics that are important to you
Cartela is a biotech company dedicated to the development of innovative therapies in arthritic diseases, primarily osteoarthritis and rheumatoid arthritis. There is still no curative treatment available for arthritic diseases and current treatment options for associated chronic pain are insufficient. A new therapeutic approach is therefore highly needed.Cartela's business is based on the cell surface molecules, integrins a10ß1 and a11ß1, which were discovered by Cartela's founder Associate Professor Evy Lundgren-Åkerlund and by Professor Donald Gullberg, respectively. These integrins play critical roles in regulating the function of chondrocytes (cartilage cells) and fibroblasts and their discovery has opened new ways for therapeutic development in arthritis.
Phone: 46 (0)46 191170.
Fax: 46 (0)46 191185.
Cartela is a biotech company dedicated to the development of innovative therapies in arthritic diseases, primarily osteoarthritis and rheumatoid arthritis. There is still no curative treatment availab...
We have published hundreds of Cartela AB news stories on BioPortfolio along with dozens of Cartela AB Clinical Trials and PubMed Articles about Cartela AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cartela AB Companies in our database. You can also find out about relevant Cartela AB Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...